Study finds women lost more of their body weight on average with semaglutide than men

FHS
June 26, 2024
9:58 am

Researchers performed a secondary analysis of the semaglutide treatment effect in people with obesity and heart failure with a preserved left ventricular ejection fraction program that included individuals with diabetes mellitus, stratified by biological sex.

New global criteria for improved diagnosis of pediatric sepsis

Diagnosis of sepsis in children has been improved based on new research findings. An international research team co-led by the Luregn Schlapbach from the University

January 25, 2024

AI-driven mammography cuts workload by 33%, boosts breast cancer detection

Implementing AI in mammography screening significantly reduces radiologists’ workload and improves breast cancer detection rates, according to a study in Denmark and the Netherlands.

June 6, 2024

Identification of Alzheimer’s disease-associated micro-RNA biomarkers through network-based analysis

Micro-ribonucleic acids (miRNAs) linked to cognition and Alzheimer’s disease (AD).

October 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.